How is Plerixafor dosed?
The recommended dose of plerixafor is 240 mcg/day. It should be administered as a daily subcutaneous injection for 6 days, starting on the 5th day after initiation of G-CSF treatment. The dose should be given by a healthcare professional in a medical setting.
What is the dosage form of Plerixafor?
Plerixafor is available in the form of a solution for injection.
How is Plerixafor administered?
Plerixafor is administered subcutaneously, meaning it is injected under the skin. It should be given by a nurse or other trained healthcare professional in a medical facility. Plerixafor is typically started after the patient has received a G-CSF medicine (such as filgrastim or pegfilgrastim) for 4 days.
What are common precautions when taking Plerixafor?
When taking plerixafor, it is important to:
- Inform your doctor about any other medical problems, allergies, or allergic reactions to medicines.
- Use effective birth control during treatment and for 1 week after the last dose, as this medicine may harm an unborn baby.
- Regularly visit your doctor for progress checks and blood tests to ensure the medicine is working properly.
- Inform your doctor if you experience any side effects or unusual reactions to the medicine.
- Be cautious if you have bone marrow cancer or other bone marrow problems, enlarged spleen, leukocytosis, or thrombocytopenia, as these conditions may worsen with the use of plerixafor.
- Be cautious if you have kidney disease, as the effects may be increased due to slower removal of the medicine from the body.
- Follow your doctor's instructions on the proper use, dosage, and frequency of the medicine.
Consult with your healthcare professional for specific precautions based on your medical history and current health conditions.